Second-Line and Third-Line Treatment Options for Metastatic HER2+ Breast Cancer

Stefania Maraka, MD, explains the second- and third-line treatment options for metastatic HER2+ breast cancer and how she collaborates with breast oncologists.

Related Videos
Experts on RCC
Experts on RCC
Experts on breast cancer
Hope S. Rugo, MD, an expert on breast cancer
Experts on RCC
Experts on RCC
Related Content